Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke


Phase 2 Results N/A

Summary of Purpose

This trial aims to test that intra-arterial injection of autologous bone marrow mononuclear cells in acute ischemic stroke patients is safe and improves neurological outcomes.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 July 2016.

1 Apr 2015 27 Jun 2014 1 Apr 2019 1 Apr 2020 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment